Weight-loss drug maker's Vogue sponsorship reignites body image debate

Eli Lilly, maker of weight-loss drugs Zepbound and Mounjaro, sponsored Vogue World Milano, drawing criticism from eating disorder advocates. During that fashion month, 97.5% of models were size four or under. The company said it wants to shift talk about weight from looks to health, but critics argue body positivity has faded as thinness quietly returns in the GLP-1 era.